From test tube to drug delivery – joint research by AstraZeneca and Glasgow

The University of Glasgow is working with global pharmaceutical company AstraZeneca to speed up the development of new medicines based on fundamental breakthroughs in science. The goal of the three-year collaboration is to identify new pathways by which inflammation can promote diseases and ultimately create better medicines for patients.

The partnership sees one of AstraZeneca’s own research teams join forces with the Institute of Infection, Immunity and Inflammation at the University of Glasgow. The research team will be fully embedded within the University as the ‘GLAZgo Discovery Centre’. The company’s investment will help support 10 full-time staff and PhD students and enable secondments between the two organisations.

The partnership draws upon Glasgow’s excellence in understanding disease pathology and immunology and combines this with the drug discovery and development expertise of AstraZeneca. By integrating the research teams the partners aim to create an innovative and collaborative atmosphere which will help achieve scientific leadership, develop new drug programmes, and inform existing AstraZeneca programmes.

Related case studies

University of Leeds – Tackling food waste with ASDA customers

Strategies to help customers waste less, from community networks, focus groups, and in-store champions

Read more >

Improving access to maternity care in developing countries

Of the thousands of maternal deaths worldwide each year, 99% occur in the developing world. This shocking marker of global inequality puts improving maternal health and reducing maternal mortality high on global policy agendas. Research into social, economic and structural barriers to maternity care carried out at King’s College London, has led to improvements in the delivery and design of maternal care worldwide.

Read more >